ArticleiScience2026
Impact of single freeze-thaw cycles on human serum proteins: Implications for mass spectrometry biomarker validation.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Functional Activity of TDP-43: A Direct Biomarker for ALS.Biosensors · 2026Article
- The effect of preanalytical factors on cerebrospinal fluid and plasma proteomics: a systematic experimental study.Clinical proteomics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Validation of biomarkers for clinical diagnostics requires high-quality samples and standardized protocols. This study investigated the effect of a single freeze-and-thaw (FT) cycle on the quality of liquid nitrogen-stored clinical serum samples. Using mass spectrometry, serum protein abundance was analyzed in a human test cohort of 99 samples and a validation cohort 109 samples. After preprocessing, 213 proteins were analyzed in the test cohort and 248 in the validation cohort. Thirty proteins changed significantly in their measurability after freeze-thaw in the test cohort, and 11 were confirmed in the validation cohort. Among them, CP and IGHV6-1 showed potential for distinguishing malignant from benign pancreatic disease. No association was found between protein intensity and storage duration. Overall, the findings show that freeze-thaw cycles are an important pre-analytical factor that should be controlled when translating protein biomarkers into clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.